hospitalization, and death. (Lack of resources)
Nirmatrelvir : severe acute respiratory syndrome coronavirus 2 main protease (Mpro) inhibitor with potent pan–human-coronavirus activity in vitro.
Ritonavir low dose 100mg (CYP3A inhibitor) : Enhancing nirmatrelvir pharmacokinetics (approximately five to six times in vitro 90% effective concentration of nirmatrelvir)
Nirmatrelvir NEJM
